These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24570340)

  • 81. Performance of the SAEM and FOCEI Algorithms in the Open-Source, Nonlinear Mixed Effect Modeling Tool nlmixr.
    Schoemaker R; Fidler M; Laveille C; Wilkins JJ; Hooijmaijers R; Post TM; Trame MN; Xiong Y; Wang W
    CPT Pharmacometrics Syst Pharmacol; 2019 Dec; 8(12):923-930. PubMed ID: 31654482
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease.
    Elstein D; Abrahamov A; Hadas-Halpern I; Meyer A; Zimran A
    QJM; 1998 Jul; 91(7):483-8. PubMed ID: 9797931
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination.
    Capablo JL; Franco R; de Cabezón AS; Alfonso P; Pocovi M; Giraldo P
    Epilepsia; 2007 Jul; 48(7):1406-8. PubMed ID: 17433057
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A Mixed Stochastic Approximation EM (MSAEM) Algorithm for the Estimation of the Four-Parameter Normal Ogive Model.
    Meng X; Xu G
    Psychometrika; 2023 Dec; 88(4):1407-1442. PubMed ID: 35648266
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Successful desensitization to imiglucerase of an adult patient diagnosed with type I Gaucher disease.
    Erdoğdu D; Gelincik A; Canbaz B; Colakoğlu B; Büyüköztürk S; Tanakol R
    Int Arch Allergy Immunol; 2013; 160(2):215-7. PubMed ID: 23018845
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of imiglucerase treatment on traumatic fracture and bone and blood abnormalities in a patient with previously untreated type 1 gaucher disease.
    Boiret-Dupré N; Descamps S; Coudoré MA; Rapatel C; Kuentz M; Pereira S; Tournadre J; Berger J; Morell P; Berger MG
    Clin Ther; 2009 Dec; 31(12):2900-4. PubMed ID: 20110029
    [TBL] [Abstract][Full Text] [Related]  

  • 87. EVALUATION OF EFFICIENCY OF IMIGLUCERASE (CEREZYME) IN THE TREATMENT OF GAUCHER DISEASE (CASE REPORTS AND REVIEW OF THE LITERATURE).
    Samohalska O; Kornaga S; Mandziy Z; Boiko T; Radetska L
    Georgian Med News; 2018 Feb; (Issue):69-73. PubMed ID: 29578427
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
    Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
    Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Gaucher disease and chitotriosidase].
    Guffon N
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S26-9. PubMed ID: 16644398
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
    El-Beshlawy A; Ragab L; Youssry I; Yakout K; El-Kiki H; Eid K; Mansour IM; Abd El-Hamid S; Yang M; Mistry PK
    J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Enzyme replacement therapy for Gaucher disease.
    Charrow J
    Expert Opin Biol Ther; 2009 Jan; 9(1):121-31. PubMed ID: 19063698
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

  • 95. Improved numerical stability for the bounded integer model.
    Ueckert S; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):241-251. PubMed ID: 33242184
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nonparametric goodness-of-fit testing for parametric covariate models in pharmacometric analyses.
    Hartung N; Wahl M; Rastogi A; Huisinga W
    CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):564-576. PubMed ID: 33755347
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
    Johansson ÅM; Ueckert S; Plan EL; Hooker AC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2014 Jun; 41(3):223-38. PubMed ID: 24801864
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A stochastic approximation expectation maximization algorithm for estimating Ramsay-curve three-parameter normal ogive model with non-normal latent trait distributions.
    Cui Y; Lu J; Zhang J; Shi N; Liu J; Meng X
    Front Psychol; 2022; 13():971126. PubMed ID: 36506999
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Classification of longitudinal profiles using semi-parametric nonlinear mixed models with P-Splines and the SAEM algorithm.
    Márquez M; Meza C; Lee DJ; De la Cruz R
    Stat Med; 2023 Nov; 42(27):4952-4971. PubMed ID: 37668286
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokinetics.
    Combes FP; Retout S; Frey N; Mentré F
    CPT Pharmacometrics Syst Pharmacol; 2014 Apr; 3(4):e109. PubMed ID: 24717242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.